Related Experiment Video
Updated: Jan 23, 2026

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
Published on: December 13, 2017
Future unmet medical need as a guiding principle for pharmaceutical R&D
Matthias Vennemann1, Vincent Ruland2, Jan-Philip Kruse3
1Business Consulting, Bayer Business Services, Leverkusen, Germany.
Abstract:
In pharmaceutical R&D the strategic focus is on addressing areas of high unmet medical need. 'Unmet medical need' is a widely used term in the healthcare sector but a common definition does not exist. The current standard of care determines the current unmet medical need, whereas the future unmet medical need (i.e., the unmet medical need when a new product reaches the market) and the extent to which the unmet need is addressed by the new product significantly impact its value. We have defined six dimensions as key drivers of (future) unmet medical needs of patients in a given setting. In the absence of quantifiable criteria, structured expert assessment techniques, such as the Delphi method, can guide portfolio strategies, especially for early-stage assets.
Related Concept Videos
The Uncertainty Principle
Pharmaceutical Equivalents
Hardy-Weinberg Principle
The Pauli Exclusion Principle
The Aufbau Principle and Hund's Rule
Le Chatelier's Principle: Changing Concentration

